Loss of RUNX3 expression promotes cancer‐associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|237|4|520-531

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.237, Iss.4, 2015-12, pp. : 520-531

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubule affinity‐regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non‐small cell lung cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 9, 2015-11 ,pp. : 2072-2082

John Wiley & Sons Inc

Access to resources Recommend Favorite

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non‐small cell lung cancer

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 2, 2015-08 ,pp. : 231-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer

By              

International Journal of Molecular Medicine, Vol. 36, Iss. 6, 2015-01 ,pp. : 1720-1726

Spandidos Publications

Access to resources Recommend Favorite

Docetaxel in non-small cell lung cancer

By Souquet Pierre-Jean   Geriniere Laurence  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 579-590

Future Medicine

Access to resources Recommend Favorite

Ifosfamide in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 50-54

Karger

Access to resources Recommend Favorite